prikaz prve stranice dokumenta Reappraisal of cardiovascular risk factors in patients with chronic myeloproliferative neoplasms
  Preuzmi
PDF 828.19 KB
Znanstveni rad - Izvorni znanstveni rad
Reappraisal of cardiovascular risk factors in patients with chronic myeloproliferative neoplasms
Clinical advances in hematology & oncology, 21 (2023), 10; 541-548. urn:nbn:hr:105:537991
Krečak, Ivan; Verstovsek, Srdan; Lucijanić, Marko

Citirajte ovaj rad

Krečak, I., Verstovsek, S. i Lucijanić, M. (2023). Reappraisal of cardiovascular risk factors in patients with chronic myeloproliferative neoplasms. Clinical advances in hematology & oncology, 21. (10), 541-548. Preuzeto s https://urn.nsk.hr/urn:nbn:hr:105:537991

Krečak, Ivan, et al. "Reappraisal of cardiovascular risk factors in patients with chronic myeloproliferative neoplasms." Clinical advances in hematology & oncology, vol. 21, br. 10, 2023, str. 541-548. https://urn.nsk.hr/urn:nbn:hr:105:537991

Krečak, Ivan, Srdan Verstovsek i Marko Lucijanić. "Reappraisal of cardiovascular risk factors in patients with chronic myeloproliferative neoplasms." Clinical advances in hematology & oncology 21, br. 10 (2023): 541-548. https://urn.nsk.hr/urn:nbn:hr:105:537991

Krečak, I., Verstovsek, S. i Lucijanić, M. (2023) 'Reappraisal of cardiovascular risk factors in patients with chronic myeloproliferative neoplasms', Clinical advances in hematology & oncology, 21(10), str. 541-548. Preuzeto s: https://urn.nsk.hr/urn:nbn:hr:105:537991 (Datum pristupa: 06.05.2024.)

Krečak I, Verstovsek S, Lucijanić M. Reappraisal of cardiovascular risk factors in patients with chronic myeloproliferative neoplasms. Clinical advances in hematology & oncology [Internet]. 10.2023. [pristupljeno 06.05.2024.];21(10):541-548. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:537991

I. Krečak, S. Verstovsek i M. Lucijanić, "Reappraisal of cardiovascular risk factors in patients with chronic myeloproliferative neoplasms", Clinical advances in hematology & oncology, vol. 21, br. 10, str. 541-548, Listopad 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:537991. [Citirano: 06.05.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:537991
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Reappraisal of cardiovascular risk factors in patients with chronic myeloproliferative neoplasms
AutorIvan Krečak
AutorSrdan Verstovsek
AutorMarko Lucijanić
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
Cardiovascular (CV) risk factors are important contributors to thrombotic risk in the general population and in patients with chronic myeloproliferative neoplasms (MPNs). However, the role of CV risk factors is often masked by other disease features that have a strong prognostic impact regarding thrombotic risk in MPN patients. This review summarizes the contemporary knowledge and aspects that have not been addressed or lack consensus in the medical community. We propose multidisciplinary care for MPN patients with CV comorbidities and provide future directions that may be needed to appropriately manage CV risk factors in MPNs.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeZavršna verzija rukopisa prihvaćena za objavljivanje (postprint)
Naslov časopisaClinical advances in hematology & oncology
Brojčani podacivol. 21, br. 10, str. 541-548
p-ISSN1543-0790
URN:NBNurn:nbn:hr:105:537991
Datum objave publikacije2023-10
URL dokumentahttps://www.hematologyandoncology.net/archives/october-2023/reappraisal-of-cardiovascular-risk-factors-in-patients-with-chronic-myeloproliferative-neoplasms/
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2024-05-06 07:58:54